Peripheral vessel wall changes in hypertensive patients with gout


Aim. To investigate the specific features of arterial wall endothelial dysfunction and stiffness in patients with hypertension concurrent with gout. Subjects and methods. A total of 54 patients were examined and divided into 2 groups. A study group consisted of 33 hypertensive patients with gout and a comparison group included 21 hypertensive patients without hyperuricemia. The patients did not differ in blood pressure (BP) readings. Uric acid was determined by the reaction with tungstophosphoric solution AT (Reagent, Dnepropetrovsk, Ukraine). The validity of results was checked using the control sera (Biocont C, Russia). Enzyme immunoassays and Doppler studies were used to investigate peripheral vasoregulation. Body mass index, intima-media thickness (IMT), pulse wave velocity (PWV), cardio-ankle vascular index (CAVI), endothelin-1 (ET-1), and endothelium-dependent vasodilation (EDVD) were determined. Results. All the studied indicators have directly or indirectly a negative impact, by deteriorating the function of the vessel wall. The found arterial structural changes suggest that there is an early atheromatous process in the arterial wall of hypertensive patients with gout. Addition of gout promotes endothelial dysfunction and worsens the course of hypertension. An elevation of indicators, such as PWV, CAVI, and ET-1 levels, has the poorest prognosis for the course of hypertension. Conclusion. The determination of CAVI, PWV, ET-1 levels, arterial stiffness index along with additional criteria, such as EDVD and IMT, may be used as criteria for a cardiovascular risk in hypertensive patients.

About the authors

B A Shelest


  1. Ильина А.Е., Барскова В.Т., Насонов Е.Л. Подагра. Гиперурикемия и кардиоваскулярный риск. Научно-практическая ревматология. 2009;1:56-63. doi: 10.14412/1995-4484-2009-143.
  2. Primatesta P, Plana E, Rothenbacher D. Gout treatment and comorbidities: a retrospective cohort study in a large US man-aged care population. BMCMusculoskelet Disord. 2011;12:103. doi: 10.1186/1471-2474-12-103.
  3. Uday M Khosla, Sergey Zharikov, Jennifer L Finch, Takahiko Nakagawa, Carlos Roncal, Wei Mu, Karina Krotova, Edward R Block, Sharma Prabhakar, Richard J Johnson. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67:1739-1742. doi: 10.1111/j.1523-1755.2005.00273.x.
  4. Коваленко В.М., Несукай О.Г., Яковенко Г.Ю. Ультразвукове дослідження брахіоцефальних судин у хворих з метаболічним синдромом та гіперурикемією. Український медичний альманах. 2008;11(4):71-73.
  5. Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T, Miyashita Y, Saiki A, Takahashi M, Suzuki K, Takata M. Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb. 2011;18(11):924-938. doi: 10.5551/jat.7716.
  6. Okura T, Watanabe S, Kurata M, Manabe S, Koresawa M, Irita J, Enomoto D, Miyoshi K, Fukuoka T, Higaki J. Relationship between Cardio-Ankle Vascular Index (CAVI) and carotid aterosclerosis in patients with essential hypertension. Hypertens Res. 2007;30(4):335-340. doi: 10.1291/hypres.30.335.
  7. Сіренко Ю.М., Радченко Г.Д., Кушнір С.М. Пульсовий артеріальний тиск та індекс жорсткості аорти: вплив на прогноз у пацієнтів з артеріальною гіпертензією, які пройшли лікування в спеціалізованому відділенні. Артеріальна гіпертензія. 2009;2(4):25-58.
  8. Celermajer DS, Sorensen KE, Gooh VM. Noninvasive detection of endothelial dysfunction in children and adults at risk atherosclerosis. Lancet. 1999;340:1111-1115. doi: 10.1016/0140-6736(92)93147-F.
  9. Carmelinda Ruggiero, Antonio Cherubini, Alessandro Ble, Angelo JG Bos, Marcello Maggio, Vishwa D Dixit, Fulvio Lauretani, Stefania Bandinelli, Umberto Senin, Luigi Ferrucci Uric acid and inflammatory markers. Eur Heart J. 2005;27(10):1174-1181. doi: 10.1093/eurheartj/ehi879.
  10. Lottmann K, Chen X, Schedlich P.K. Association between gout and all-cause as well as cardiovascular mortality: a systematic review. Curr Rheumatol Rep. 2012;14(2):195-203. doi: 10.1007/s11926-011-0234-2.



Abstract - 104

PDF (Russian) - 17


Article Metrics

Metrics Loading ...


  • There are currently no refbacks.

Copyright (c) 2020 Shelest B.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:


© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies